Dubai
Keelhouse Ventures
Reduce fragility. Preserve optionality. Think across cycles.
Applied AI. Proprietary data. Structured for exit.
01 · Thesis
A founder-led investment company building ventures from one balance sheet.
Keelhouse Ventures backs structural businesses, not narratives. Each venture is selected for its exit architecture, its data layer, and its ability to compound inside the holding entity.
Investors hold equity in Keelhouse Ventures. Ventures, in turn, holds the operating businesses. One vehicle. One P&L. No fund mechanics, no carry, no management fee on undeployed capital.
02 · Portfolio
Three live ventures. One under evaluation. Two in development.
The ventures Keelhouse holds today. Names and operating detail remain private until launch.
Project · 01 · Active
Consumer behavioural telemetry
Travel and lifestyle. Horizontal data layer.
Live · In user acquisition
Project · 02 · Active
Oncology vertical cohort
Healthcare. Care-pathway and member acquisition.
Live · Build and partnership
Project · 03 · Active
Population-scale health telemetry
Wearables data layer. Lifestyle-tier consent.
Live · Dataset accumulation
Project · 04 · Active
Structural Performance Audit
A Keelhouse Labs engagement for founder-led businesses.
Disclosure. Two further ventures are in development with sector and structure undisclosed. Project names, buyer profiles, and capital structure are released to investors under NDA.
03 · AI Posture
Applied AI, with proprietary data behind every venture.
Every Keelhouse venture is built with AI at its core. As the product, as the moat, or as the operating leverage. The connective tissue across the portfolio is not a sector. It is a data layer.
Each venture either captures a dataset incumbents cannot replicate, applies AI to a domain where structural inefficiencies are large, or runs AI-supervised execution inside Labs. In every case, AI is controlled. Rules govern decisions. Models propose improvements. A human approves before logic changes.
i
Proprietary data
Each venture accumulates a dataset that cannot be replicated by acquisition.
ii
Applied, not generic
AI is deployed against specific structural problems. No general-purpose AI products.
iii
Controlled execution
The most appropriate AI stack is selected per venture. Models propose. Humans approve. Rules execute.
04 · Labs
Keelhouse Labs is the operating arm of Keelhouse Ventures.
Labs is not a separate company, a separate fund, or a separate offering. It is the internal function that builds, operates, and exits every venture inside the Keelhouse balance sheet.
Investors back Ventures. Labs is how Ventures executes. Founder-led. Multi-disciplinary. With in-house product, capital allocation, and exit-architecture capability across consumer, health, fintech and trading systems.
i
Single P&L
Every venture is funded from the Ventures balance sheet. Operating cost is absorbed inside the holding entity.
ii
Two-axis design
Every venture fits one of two exit architectures. Horizontal telemetry licensing or vertical cohort acquisition.
iii
Capital discipline
No management fee on undeployed capital. Concentration caps and defined kill criteria at every venture initiation.
05 · Process
How Keelhouse evaluates, allocates, and exits.
A short, repeatable sequence applied to every venture inside Keelhouse, internal or external founder.
i
Identify
Structural opportunity sourced through founder pattern recognition or inbound diligence.
ii
Architect
Exit architecture assigned. Buyer pool mapped. Two-axis fit confirmed.
iii
Build
Funded from balance sheet. Operated by Labs. Concentration capped at initiation.
iv
Exit
Licensed, acquired, or held as a long-duration position inside Ventures.
06 · Investors
Open to a limited number of aligned investors.
The full investor deck, vehicle structure, named project dossiers, and capital plan are released under NDA.